Related references
Note: Only part of the references are listed.Biotransformations of Anticancer Ruthenium(III) Complexes: An X-Ray Absorption Spectroscopic Study
Aviva Levina et al.
CHEMISTRY-A EUROPEAN JOURNAL (2013)
Transferrin Serves As a Mediator to Deliver Organometallic Ruthenium(II) Anticancer Complexes into Cells
Wei Guo et al.
INORGANIC CHEMISTRY (2013)
Application of Bio-Layer Interferometry for the analysis of protein/liposome interactions
Jakob Wallner et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2013)
Uptake and release of metal ions by transferrin and interaction with receptor 1
Jean-Michel El Hage Chahine et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2012)
Kinetics of iron release from transferrin bound to the transferrin receptor at endosomal pH
Ashley N. Steere et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2012)
The binding and transport of alternative metals by transferrin
John B. Vincent et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2012)
The intracellular trafficking pathway of transferrin
Kristine M. Mayle et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2012)
Approaching tumour therapy beyond platinum drugs Status of the art and perspectives of ruthenium drug candidates
A. Bergamo et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2012)
Protein microarrays, biosensors, and cell-based methods for secretome-wide extracellular protein-protein interaction mapping
Lino C. Gonzalez
METHODS (2012)
Cleavage of a putative metal permease in Chlamydia trachomatis yields an iron-dependent transcriptional repressor
Christopher C. Thompson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Pharmacokinetic study of sodium trans[tetrachlorobis(1H-indazole)-ruthenate (III)]/-indazole hydrochloride (1:1.1) (FFC14A) in patients with solid tumors
M.M. Henke et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS (2011)
Characterization of a Ruthenium(III)/NAMI-A Adduct with Bovine Serum Albumin that Exhibits a High Anti-Metastatic Activity
Mimi Liu et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2010)
Recent developments in ruthenium anticancer drugs
Aviva Levina et al.
METALLOMICS (2009)
Transferrin binding and transferrin-mediated cellular uptake of the ruthenium coordination compound KP1019, studied by means of AAS, ESI-MS and CD spectroscopy
M Pongratz et al.
JOURNAL OF ANALYTICAL ATOMIC SPECTROMETRY (2004)
A phase I and pharmacological study with imidazolium-trans-DMSO-imidazole-tetrachlororuthenate, a novel ruthenium anticancer agent
JM Rademaker-Lakhai et al.
CLINICAL CANCER RESEARCH (2004)
Lodination significantly influences the binding of human transferrin to the transferrin receptor
H Fuchs et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2002)
Share Paper
